Chemo Side Affects San Francisco CA

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo.

Local Companies

LightHouse for the Blind and Visually Impaired
(415) 431-1481
214 Van Ness Ave.
San Francisco, CA
St. Mary's Medical Center - CHW
(415) 750-5798
450 Stanyan St.
San Francisco, CA
For Your Eyes Only
(415) 626-0858
552 Castro St.
San Francisco, CA
California Pacific Medical Center - St. Luke's Campus
(415) 647-8600
3555 Cesar Chavez St.
San Francisco, CA
San Francisco General Hospital
(415) 206-8000
1001 Potrero Ave., 2A5
San Francisco, CA
California Institute for Quantitative Biosciences - QB3
(415) 514-0265
1700 Fourth St., Byers Hall 214, MC 2522
San Francisco, CA
Brown & Toland Medical Group
(415) 972-6000
153 Townsend St., Ste. 700
San Francisco, CA
Planned Parenthood
(415) 441-7858
815 Eddy St.
San Francisco, CA
San Francisco Health Center
800-967-7526
815 Eddy Street, 2nd Floor
San Francisco, CA
Sassan Kafayi DDS
(415) 397-2244
450 Sutter St., Ste. 2104
San Francisco, CA

A drug that better prevents the nausea and vomiting that commonly follows chemotherapy treatment for cancer may be on the horizon, Japanese researchers report.

Studies headed by a doctor at Juntendo University Hospital in Tokyo found that palonosetron was not only as effective as the common anti-nausea drug granisetron at avoiding the sickening side effects in the first 24 hours after chemo, but is even better at preventing those side effects in the first five days.

In the phase III trial, about three-fourths of the people given either drug (both given in combination with dexamethasone) did not experience nausea and vomiting in the 24 hours immediately after receiving a chemotherapy regimen that included drugs most likely to cause vomiting -- cisplatin or a combination of anthracycline and cyclophosphamide, according to the study. However, nearly 57 percent of those on palonosetron avoided the ill effects in the first five days after treatment, compared with about 44 percent who had been given the standard granisetron regimen.

The study, which was released online and will appear in the February issue of The Lancet Oncology, reported similar safety records for the two drugs.

More information

The National Cancer Institute has more about chemotherapy side effects.

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009

SOURCE: The Lancet Oncology, news release, Jan. 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Featured Local Company

LightHouse for the Blind and Visually Impaired

(415) 431-1481
214 Van Ness Ave.
San Francisco, CA

Related Local Events
BIOMEDevice
Dates: 12/9/2009 - 12/10/2009
Location: San Jose Convention Center, San Jose
San Jose, CA
View Details

AEBE 2010
Dates: 11/18/2009 - 11/20/2009
Location: Santa Clara Convention Center
Santa Clara, CA
View Details

The Fetus and Newborn : State-of-the-Art Care Conference
Dates: 10/27/2009 - 10/31/2009
Location: Hyatt Regency Hotel
San Francisco, CA
View Details

Advanced Critical Care and Trauma Conference
Dates: 10/17/2009 - 10/20/2009
Location: Hyatt Regency Hotel
San Francisco, CA
View Details

International Contract Services Expo-USA (ICSE USA)
Dates: 10/13/2009 - 10/15/2009
Location: San Francisco Exhibition Centre, San Francisco
San Francisco, CA
View Details